rs2228952

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001130438.3(SPTAN1):​c.7389C>T​(p.Thr2463Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0044 in 1,614,000 control chromosomes in the GnomAD database, including 254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 118 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 136 hom. )

Consequence

SPTAN1
NM_001130438.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.11

Publications

3 publications found
Variant links:
Genes affected
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]
SPTAN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronopathy, distal hereditary motor, autosomal dominant 11
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 9-128633289-C-T is Benign according to our data. Variant chr9-128633289-C-T is described in ClinVar as Benign. ClinVar VariationId is 139320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0781 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
NM_001130438.3
MANE Select
c.7389C>Tp.Thr2463Thr
synonymous
Exon 57 of 57NP_001123910.1Q13813-2
SPTAN1
NM_001375318.1
c.7488C>Tp.Thr2496Thr
synonymous
Exon 59 of 59NP_001362247.1
SPTAN1
NM_001375310.1
c.7476C>Tp.Thr2492Thr
synonymous
Exon 58 of 58NP_001362239.1A0A994J6W3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
ENST00000372739.7
TSL:1 MANE Select
c.7389C>Tp.Thr2463Thr
synonymous
Exon 57 of 57ENSP00000361824.4Q13813-2
SPTAN1
ENST00000372731.8
TSL:1
c.7374C>Tp.Thr2458Thr
synonymous
Exon 56 of 56ENSP00000361816.4Q13813-1
SPTAN1
ENST00000358161.9
TSL:1
c.7314C>Tp.Thr2438Thr
synonymous
Exon 55 of 55ENSP00000350882.6Q13813-3

Frequencies

GnomAD3 genomes
AF:
0.0230
AC:
3497
AN:
152164
Hom.:
119
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0805
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00707
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.00608
AC:
1528
AN:
251274
AF XY:
0.00446
show subpopulations
Gnomad AFR exome
AF:
0.0820
Gnomad AMR exome
AF:
0.00379
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000211
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00246
AC:
3598
AN:
1461718
Hom.:
136
Cov.:
32
AF XY:
0.00215
AC XY:
1561
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0867
AC:
2903
AN:
33480
American (AMR)
AF:
0.00432
AC:
193
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
37
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000441
AC:
38
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53254
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.000109
AC:
121
AN:
1112010
Other (OTH)
AF:
0.00474
AC:
286
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
219
437
656
874
1093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0230
AC:
3502
AN:
152282
Hom.:
118
Cov.:
33
AF XY:
0.0220
AC XY:
1636
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0804
AC:
3340
AN:
41550
American (AMR)
AF:
0.00706
AC:
108
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68020
Other (OTH)
AF:
0.0166
AC:
35
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
169
337
506
674
843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00900
Hom.:
36
Bravo
AF:
0.0263
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Developmental and epileptic encephalopathy, 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.99
DANN
Benign
0.94
PhyloP100
-1.1
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228952; hg19: chr9-131395568; API